A new platform can help cancer patients and other people living with chronic diseases.
The University of Pittsburgh Schools of the Health Sciences (UPMC) has recently founded Realyze Intelligence, a company that has a platform that will leverage natural language processing and artificial intelligence to identify the best treatments for chronic disease and cancer patients — reading both the detailed clinical notes and structured data from patients’ electronic medical records (EMR).
“Patients aren't defined by their primary diagnosis. They are not just dealing with that one condition, but also many other factors that make them complex, and it currently is a manual, time-consuming effort to extract and use the relevant information from the EMR to ensure effective care,” Dr. Gilan El Saadawi, chief medical officer at Realyze Intelligence, told the UPMC website. “Realyze streamlines this process and quickly decodes the patient’s ‘story’ so they get the best care.”
The platform will help doctors determine those who need the most urgent medical attention and should be prioritized.
Physicians can further aid their patients in healing as they are able to get valuable insights and predict chronic conditions and risk factors with the platform’s natural language processing, which involves machine learning and artificial intelligence.
Another program can predict a patient’s risk of COVID-19 cases of dialysis and death, the Health IT Analytics reported.
